{"id":"https://openalex.org/W2003153226","doi":"https://doi.org/10.1177/147323000303100205","title":"A Single Ascending Dose Study of Epigallocatechin Gallate in Healthy Volunteers","display_name":"A Single Ascending Dose Study of Epigallocatechin Gallate in Healthy Volunteers","publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W2003153226","doi":"https://doi.org/10.1177/147323000303100205","mag":"2003153226","pmid":"https://pubmed.ncbi.nlm.nih.gov/12760312"},"language":"en","primary_location":{"id":"doi:10.1177/147323000303100205","doi":"https://doi.org/10.1177/147323000303100205","is_oa":false,"landing_page_url":"https://doi.org/10.1177/147323000303100205","pdf_url":null,"source":{"id":"https://openalex.org/S62018274","display_name":"Journal of International Medical Research","issn_l":"0300-0605","issn":["0300-0605","1473-2300"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of International Medical Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"U Ullmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"U Ullmann","raw_affiliation_strings":["Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113516729","display_name":"J\u00fcrg Haller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"J Haller","raw_affiliation_strings":["Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland;","1 Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"1 Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018794013","display_name":"J Decourt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018756631","display_name":"Institut des Mondes Africains","ror":"https://ror.org/02qprbz18","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I159885104","https://openalex.org/I21491767","https://openalex.org/I2746051580","https://openalex.org/I2802818602","https://openalex.org/I3018756631","https://openalex.org/I4210090127","https://openalex.org/I4210131494","https://openalex.org/I4210166444","https://openalex.org/I51101395","https://openalex.org/I90669466"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"JP Decourt","raw_affiliation_strings":["PAREXEL-CEMAF, Clinical Department, Poitiers, France","2 PAREXEL-CEMAF, Clinical Department, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":["https://openalex.org/I3018756631"]},{"raw_affiliation_string":"2 PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000851613","display_name":"N Girault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018756631","display_name":"Institut des Mondes Africains","ror":"https://ror.org/02qprbz18","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I159885104","https://openalex.org/I21491767","https://openalex.org/I2746051580","https://openalex.org/I2802818602","https://openalex.org/I3018756631","https://openalex.org/I4210090127","https://openalex.org/I4210131494","https://openalex.org/I4210166444","https://openalex.org/I51101395","https://openalex.org/I90669466"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N Girault","raw_affiliation_strings":["PAREXEL-CEMAF, Clinical Department, Poitiers, France","2 PAREXEL-CEMAF, Clinical Department, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":["https://openalex.org/I3018756631"]},{"raw_affiliation_string":"2 PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111864218","display_name":"J. Girault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018756631","display_name":"Institut des Mondes Africains","ror":"https://ror.org/02qprbz18","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I159885104","https://openalex.org/I21491767","https://openalex.org/I2746051580","https://openalex.org/I2802818602","https://openalex.org/I3018756631","https://openalex.org/I4210090127","https://openalex.org/I4210131494","https://openalex.org/I4210166444","https://openalex.org/I51101395","https://openalex.org/I90669466"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J Girault","raw_affiliation_strings":["PAREXEL-CEMAF, Clinical Department, Poitiers, France","2 PAREXEL-CEMAF, Clinical Department, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":["https://openalex.org/I3018756631"]},{"raw_affiliation_string":"2 PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022883422","display_name":"AS Richard-Caudron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018756631","display_name":"Institut des Mondes Africains","ror":"https://ror.org/02qprbz18","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I159885104","https://openalex.org/I21491767","https://openalex.org/I2746051580","https://openalex.org/I2802818602","https://openalex.org/I3018756631","https://openalex.org/I4210090127","https://openalex.org/I4210131494","https://openalex.org/I4210166444","https://openalex.org/I51101395","https://openalex.org/I90669466"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"AS Richard-Caudron","raw_affiliation_strings":["PAREXEL-CEMAF, Clinical Department, Poitiers, France","2 PAREXEL-CEMAF, Clinical Department, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":["https://openalex.org/I3018756631"]},{"raw_affiliation_string":"2 PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"B Pineau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018756631","display_name":"Institut des Mondes Africains","ror":"https://ror.org/02qprbz18","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I159885104","https://openalex.org/I21491767","https://openalex.org/I2746051580","https://openalex.org/I2802818602","https://openalex.org/I3018756631","https://openalex.org/I4210090127","https://openalex.org/I4210131494","https://openalex.org/I4210166444","https://openalex.org/I51101395","https://openalex.org/I90669466"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B Pineau","raw_affiliation_strings":["PAREXEL-CEMAF, Clinical Department, Poitiers, France","2 PAREXEL-CEMAF, Clinical Department, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":["https://openalex.org/I3018756631"]},{"raw_affiliation_string":"2 PAREXEL-CEMAF, Clinical Department, Poitiers, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108222051","display_name":"Peter Weber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"P Weber","raw_affiliation_strings":["Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland;","1 Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"1 Roche Vitamins Ltd, Human Nutrition and Health, Research and Development, Basel, Switzerland;","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":4155,"currency":"USD","value_usd":4155},"apc_paid":null,"fwci":6.1179,"has_fulltext":false,"cited_by_count":299,"citation_normalized_percentile":{"value":0.9656828,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"31","issue":"2","first_page":"88","last_page":"101"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11411","display_name":"Tea Polyphenols and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11411","display_name":"Tea Polyphenols and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10035","display_name":"Phytochemicals and Antioxidant Activities","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11264","display_name":"Coffee research and impacts","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epigallocatechin-gallate","display_name":"epigallocatechin gallate","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7450000047683716},{"id":"https://openalex.org/keywords/single-ascending-dose","display_name":"single ascending dose","score":0.7279999852180481},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.8460000157356262},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.9089999794960022},{"id":"https://openalex.org/keywords/plasma-concentration-time-curve","display_name":"plasma concentration-time curve","score":0.6700000166893005},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9139999747276306},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.49900001287460327},{"id":"https://openalex.org/keywords/green-tea-polyphenols","display_name":"green tea polyphenols","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8785486817359924},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7188609838485718},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6918162107467651},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.5847383141517639},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5604798197746277},{"id":"https://openalex.org/C2777192995","wikidata":"https://www.wikidata.org/wiki/Q393339","display_name":"Epigallocatechin gallate","level":4,"score":0.4926336407661438},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4160902500152588},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.41164132952690125},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3801819086074829},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37450093030929565},{"id":"https://openalex.org/C140793950","wikidata":"https://www.wikidata.org/wiki/Q168091","display_name":"Animal science","level":1,"score":0.3618488907814026},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3584635853767395},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.31286126375198364},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.1720810830593109},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.17187651991844177},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11120674014091492},{"id":"https://openalex.org/C70899900","wikidata":"https://www.wikidata.org/wiki/Q290439","display_name":"Polyphenol","level":3,"score":0.08425506949424744},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000042","descriptor_name":"Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015990","descriptor_name":"Placebo Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/147323000303100205","doi":"https://doi.org/10.1177/147323000303100205","is_oa":false,"landing_page_url":"https://doi.org/10.1177/147323000303100205","pdf_url":null,"source":{"id":"https://openalex.org/S62018274","display_name":"Journal of International Medical Research","issn_l":"0300-0605","issn":["0300-0605","1473-2300"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of International Medical Research","raw_type":"journal-article"},{"id":"pmid:12760312","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12760312","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of international medical research","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1096224411","https://openalex.org/W1532725392","https://openalex.org/W1569637190","https://openalex.org/W1887275565","https://openalex.org/W1926509225","https://openalex.org/W1967557898","https://openalex.org/W1976359024","https://openalex.org/W1980160486","https://openalex.org/W1990815506","https://openalex.org/W1999108312","https://openalex.org/W1999208146","https://openalex.org/W2008447698","https://openalex.org/W2013681582","https://openalex.org/W2014882636","https://openalex.org/W2030967356","https://openalex.org/W2031114601","https://openalex.org/W2034475576","https://openalex.org/W2056560062","https://openalex.org/W2063104057","https://openalex.org/W2075380466","https://openalex.org/W2090516886","https://openalex.org/W2112879571","https://openalex.org/W2117912144","https://openalex.org/W2120595047","https://openalex.org/W2125565767","https://openalex.org/W2133530101","https://openalex.org/W2152655991","https://openalex.org/W2153663340","https://openalex.org/W2157079407","https://openalex.org/W2162854127","https://openalex.org/W2298006004","https://openalex.org/W2485328716","https://openalex.org/W2764451377"],"related_works":["https://openalex.org/W2135785702","https://openalex.org/W1434067428","https://openalex.org/W3027808787","https://openalex.org/W2014882636","https://openalex.org/W2294960936","https://openalex.org/W2125565767","https://openalex.org/W2980316619","https://openalex.org/W2523287507","https://openalex.org/W1980386603","https://openalex.org/W2105408725"],"abstract_inverted_index":{"This":[0],"randomized,":[1],"double-blind,":[2],"placebo-controlled":[3],"study":[4],"assessed":[5],"the":[6,77,86,93,98,103,121],"safety,":[7],"tolerability":[8,114],"and":[9,60,102,113,145,158,172,186,200],"plasma":[10,88,130],"kinetic":[11,122],"behaviour":[12],"of":[13,17,36,46,91,108,141,152,192],"single":[14,44],"oral":[15,41,190],"doses":[16,45,191],"94%":[18],"pure":[19],"crystalline":[20],"bulk":[21],"epigallocatechin":[22],"gallate":[23],"(EGCG)":[24],"under":[25,76],"fasting":[26],"conditions":[27],"in":[28,43],"60":[29],"healthy":[30],"male":[31],"volunteers.":[32],"In":[33,117],"each":[34,118],"group":[35],"10":[37],"subjects,":[38],"eight":[39],"received":[40,62],"EGCG":[42,109,154,193],"50":[47],"mg,":[48,50,52,54,59],"100":[49],"200":[51],"400":[53],"800":[55],"mg":[56,197],"or":[57],"1600":[58,196],"two":[61],"placebo.":[63],"Blood":[64],"samples":[65],"were":[66,110,115,173,182,198],"taken":[67,95],"at":[68],"intervals":[69],"until":[70],"26":[71],"h":[72,82],"later.":[73],"The":[74,149,161,178],"area":[75],"concentration-time":[78],"curve":[79],"from":[80,167],"0":[81],"to":[83,96,169,195],"infinity":[84],"(AUC(0-infinity)),":[85],"maximum":[87,99],"concentration":[89,100,131],"(Cmax)":[90],"EGCG,":[92],"time":[94,133],"reach":[97],"(Tmax),":[101],"terminal":[104],"elimination":[105,147],"half-life":[106],"(t1/2z)":[107],"determined.":[111],"Safety":[112],"assessed.":[116],"dosage":[119],"group,":[120],"profile":[123],"revealed":[124],"rapid":[125],"absorption":[126],"with":[127],"a":[128,137,142],"one-peak":[129],"versus":[132],"course,":[134],"followed":[135],"by":[136],"multiphasic":[138],"decrease":[139],"consisting":[140],"distribution":[143],"phase":[144],"an":[146],"phase.":[148],"mean":[150,163,179],"AUC(0-infinity)":[151],"total":[153],"varied":[155],"between":[156,184],"442":[157],"10,368":[159],"ng.h/ml.":[160],"according":[162],"Cmax":[164],"values":[165,181],"ranged":[166],"130":[168],"3392":[170],"ng/ml":[171],"observed":[174],"after":[175],"1.3-2.2":[176],"h.":[177,188],"t1/2z":[180],"seen":[183],"1.9":[185],"4.6":[187],"Single":[189],"up":[194],"safe":[199],"very":[201],"well":[202],"tolerated.":[203]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":21}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}